4 questions about the FDA’s approach to generative AI
Published . Updated .
The medtech industry is awaiting FDA guidance on generative AI. The agency has sought feedback in advisory meetings and a discussion paper as the technology becomes more prevalent.
Directly affected
- No company is named in this report.
Indirectly affected
- CHAT Roundhill Generative AI & Tech
GA selected CHAT as a RELATED security because its canonical security name directly matches this event's themes: generative, ai. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- SUPX SUPERX AI TECHNOLOGY LTD
GA selected SUPX as a RELATED security because its canonical security name directly matches this event's themes: technology, ai. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ABAT AMERICAN BATTERY TECHNOLOGY
GA selected ABAT as a RELATED security because its canonical security name directly matches this event's themes: technology. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ACHC ACADIA HEALTHCARE COMPANY INC
GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ACM AECOM TECHNOLOGY CORP
GA selected ACM as a RELATED security because its canonical security name directly matches this event's themes: technology. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- AOSL ALPHA & OMEGA SEMICONDUCTOR LT SHS
GA selected AOSL as a RELATED security because its canonical security name directly matches this event's themes: semiconductor. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
The medtech industry is awaiting FDA guidance on generative AI. The agency has sought feedback in advisory meetings and a discussion paper as the technology becomes more prevalent.
Source: MedTech Dive
The price since 12 Sep 2026: Roundhill Generative AI & Tech (CHAT) versus the S&P 500
Since the first closing price after “4 questions about the FDA’s approach to generative AI,” Roundhill Generative AI & Tech (CHAT) is -5.68%. The S&P 500 fund (SPY) is +0.77% over the same days, a -6.45% difference versus the market.
Official trades in Roundhill Generative AI & Tech (CHAT) around 12 Sep 2026
- Donald J Trump buy Aecom (ACM) ($1,001 - $15,000). That is 15 days before publication, inside 30 days. The filing is listed beside the story “4 questions about the FDA’s approach to generative AI.”
- Donald J Trump sell Aecom (ACM) ($1,001 - $15,000). That is 19 days before publication, inside 30 days. The filing is listed beside the story “4 questions about the FDA’s approach to generative AI.”
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “4 questions about the FDA’s approach to generative AI”
Companies mentioned with this story
- CHAT Roundhill Generative AI & Tech
In “4 questions about the FDA’s approach to generative AI,” Roundhill Generative AI & Tech (CHAT) is linked, with no stored direction, medium confidence. Reason on file: GA selected CHAT as a RELATED security because its canonical security name directly matches this event's themes: generative, ai. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- SUPX SuperX AI Technology
In “4 questions about the FDA’s approach to generative AI,” SuperX AI Technology (SUPX) is linked, with no stored direction, medium confidence. Reason on file: GA selected SUPX as a RELATED security because its canonical security name directly matches this event's themes: technology, ai. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ABAT American Battery Technology
In “4 questions about the FDA’s approach to generative AI,” American Battery Technology (ABAT) is linked, with no stored direction, medium confidence. Reason on file: GA selected ABAT as a RELATED security because its canonical security name directly matches this event's themes: technology. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ACHC Acadia Healthcare
In “4 questions about the FDA’s approach to generative AI,” Acadia Healthcare (ACHC) is linked, with no stored direction, medium confidence. Reason on file: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ACM Aecom
Aecom (ACM) is linked, with no stored direction, medium confidence in the 12 Sep 2026 story “4 questions about the FDA’s approach to generative AI.” Reason on file: GA selected ACM as a RELATED security because its canonical security name directly matches this event's themes: technology. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- AOSL Alpha & Omega Semiconductor
In “4 questions about the FDA’s approach to generative AI,” Alpha & Omega Semiconductor (AOSL) is linked, with no stored direction, medium confidence. Reason on file: GA selected AOSL as a RELATED security because its canonical security name directly matches this event's themes: semiconductor. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “4 questions about the FDA’s approach to generative AI” reaches Roundhill Generative AI & Tech (CHAT)
The 12 Sep 2026 story “4 questions about the FDA’s approach to generative AI” names Roundhill Generative AI & Tech (CHAT) because of this story.
Roundhill Generative AI & Tech (CHAT) is on the page because GA selected CHAT as a RELATED security because its canonical security name directly matches this event's themes: generative, ai. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
A second company, SuperX AI Technology (SUPX), is listed for a different reason: GA selected SUPX as a RELATED security because its canonical security name directly matches this event's themes: technology, ai. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates in the story, and the Roundhill Generative AI & Tech (CHAT) price range
ABAT traded between 1.42 and 2.42 across 20 sessions. The latest close on file is 1.44. CHAT traded between 78.71 and 96.70 across 20 sessions. The latest close on file is 80.30. SUPX traded between 6.15 and 7.09 across 10 sessions. The latest close on file is 6.72.
What the saved facts support for Roundhill Generative AI & Tech (CHAT)
46 out of 100
“4 questions about the FDA’s approach to generative AI” scores 46 out of 100. The score uses 1 sources, and 6 linked companies.